Expansions
LabGenetics has almost 20 years of experience in the study of repeat expansions. We have oligonucleotides designed and validated for the molecular approach of diseases caused by repeat expansions (screening PCR and TP-PCR).
Expansions that we carry out:
SCA Panel-1: SCA1, SCA2&SCA3 – Expansion + TP-PCR
SCA Panel-2: SCA6, SCA7&SCA8 – Expansion + TP-PCR
SCA Panel-3: SCA10, SCA12, SCA17, SCA36- Expansion+TP-PCR
CAG triplet expansion of the SCA1 gene (ATXN1) + TP-PCR
CAG triplet expansion of the SCA2 gene (ATXN2) + TP-PCR
CAG triplet expansion of the SCA3 gene (ATXN3) + TP-PCR
CAG triplet expansion of the SCA6 gene (CACNA1A) + TP-PCR
CAG triplet expansion of the SCA7 gene (ATXN7) + TP-PCR
(CTA) expansion analysis (CTG) of the SCA8 gene (ATXN8OS)
ATTCT expansion analysis of the SCA10 gene (ATXN10)
CAG triplet expansion of the SCA12 gene (PPP2R2B) + TP-PCR
CAA/CAG expansion analysis of the SCA17 gene (TBP)
(GGCCTG)n expansion in the NOP56 gene (SCA36) + TP-PCR
CAG triplet expansion analysis of the DRPLA (atrophin 1) gene
Analysis of the CAG triplet expansion of the AR gene
Analysis of the (GCN)n expansion in exon 1 – HOXD13 gene
Analysis of the CAG triplet expansion of the HTT (HD) gene
Analysis of the expansion of the CTG triplet of the JPH3 gene
Expansion (GGGGCC)n in the C9ORF72 gene (incl. TP-PCR)
Analysis of the CTG triplet expansion of the DMPK gene: Screening + TP-PCR (Triplet Repeat Primed PCR)
Analysis of the CCTG expansion of the CNBP gene (ZNF9)
Detection of CGC expansion in the PABPN1 gene
Expansion of a dodecamer in the CSTB gene (EPM1A)
Expansion (GGGGCC)n in the C9ORF72 gene (incl. TP-PCR)
Analysis of the (GCN)n expansion in exon 1 – HOXD13 gene
Analysis of poly-Ala triplet expansion of the PHOX2B gene
Expansion of a dodecamer in the CSTB gene (EPM1A)
PCR-Screening of the CGG triplet expansion – FMR-1 gene
SEARCH BY DISEASE OR GENE
Request information
LabGenetics offers a comprehensive genetic diagnostic service, personalized, flexible to the requirements of health professionals, and continuously introduces new genetic diagnostics of hereditary and rare diseases in its portfolio of services. Our goal is to establish close collaborations that allow us to obtain accurate and appropriate results for each case, as quickly and economically as possible.